D-0269-2022 Class III Terminated
FDA drug recall D-0269-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 5016 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 15, 2021
- Initiation Date
- Nov 12, 2021
- Termination Date
- Jun 23, 2023
- Product Quantity
- 5016 cartons
Product description
Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets USP Allergy & Congestion, 20 Tablets, Distributed by: Dr. Reddy's Laboratories, Inc. Princeton, NJ 08540, NDC 43598-823-14.
Reason for recall
Failed dissolution specifications
Distribution pattern
USA Nationwide.
Code information
Lot #: AC2103329F, Exp 1/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0269-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026